HIGHLIGHTS
- who: Daniele Tibullo and collaborators from the Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, University of Catania, Catania, Italy have published the article: Ixazomib Improves Bone Remodeling and Counteracts Sonic Hedgehog Signaling Inhibition Mediated by Myeloma Cells, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate the effects of Ixazomib a third-generation proteasome inhibitor on osteoclastogenesis and osteogenic differentiation. Given the increased therapeutic potential of third-generation PIs, the authors focused the attention on Ixazomib-induced effects on osteoclastogenesis and osteoblastogenesis. The authors showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.